Christopher Bork

Christopher Bork is a Biologics Drug Substance Technical Leader at Genentech, bringing extensive experience in bioprocess engineering and bioseparation technologies. Previously, they held positions at Biogen Idec, where they developed purification processes for monoclonal antibodies, and at Sigma Aldrich, supervising large-scale production of immunochemicals. With a B.S. in Microbiology from the University of Michigan and an M.B.A. in Management from Fontbonne University, they have demonstrated strong leadership skills and a track record of process improvement initiatives to achieve corporate goals.